A RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA AFTER 1ST RECURRENCE: A REPORT FROM THE JAPAN NEUROBLASTOMA STUDY GROUP

被引：0
|
作者：
Hara, Junichi [1 ]
Takimoto, Tetsuya [2 ]
Shichino, Hiroyuki [3 ]
Matsumoto, Kimikazu [4 ]
Kuroda, Tatsuo [5 ]
Hishiki, Tomoro [6 ]
Soejima, Toshinori [7 ]
Hashii, Yoshiko [8 ]
Mori, Tetsuya [9 ]
Ikeda, Hitoshi [10 ]
机构：
[1] Osaka City Gen Hosp, Osaka, Japan
[2] Natl Ctr Child Hlth & Dev, Tokyo, Japan
[3] Nihon Univ, Tokyo, Japan
[4] Japanese Red Cross Nagoya First Hosp, Nagoya, Aichi, Japan
[5] Keio Univ, Tokyo, Japan
[6] Chiba Univ, Grad Sch Med, Chiba, Japan
[7] Hyogo Prefectural Canc Ctr, Akashi, Hyogo, Japan
[8] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
[9] Natl Ctr Child Hlth & Dev, Tokyo, Japan
[10] Dokkyo Med Univ, Koshigaya Hosp, Koshigaya, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1059 / 1059
页数：1
相关论文
共 50 条
  • [41] A Phase 1/2 Study of Autologous Neuroblastoma Tumor Cells Genetically Modified to Secrete IL-2 in Patients With High-risk Neuroblastoma
    Russell, Heidi V.
    Strother, Douglas
    Mei, Zhuyong
    Rill, Donna
    Popek, Edwina
    Biagi, Ettore
    Yvon, Eric
    Brenner, Malcolm
    Rousseau, Raphael
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 812 - 819
  • [42] Predictors of differential response to induction therapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG)
    Pinto, Navin
    Naranjo, Arlene
    Hibbitts, Emily
    Kreissman, Susan G.
    Granger, M. Meaghan
    Irwin, Meredith S.
    Bagatell, Rochelle
    London, Wendy B.
    Greengard, Emily G.
    Park, Julie R.
    Dubois, Steven G.
    EUROPEAN JOURNAL OF CANCER, 2019, 112 : 66 - 79
  • [43] Predictors of differential response to induction chemotherapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG).
    Pinto, Navin R.
    Hibbitts, Emily
    Kreissman, Susan G.
    Granger, Meaghan P.
    Irwin, Meredith
    Bagatell, Rochelle
    London, Wendy B.
    Greengard, Emily Gustava
    Naranjo, Arlene
    Park, Julie R.
    DuBois, Steven G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY AIMED AT VALIDATING A PROGNOSTIC VALUE OF MINIMAL RESIDUAL DISEASE IN HIGH-RISK NEUROBLASTOMA PATIENTS
    Nishimura, Noriyuki
    Ishida, Toshiaki
    Yokota, Isao
    Matsumoto, Kimikazu
    Shichino, Hiroyuki
    Kamijo, Takehiko
    Takimoto, Tetsuya
    Iehara, Tomoko
    Tajiri, Tatsuro
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S13 - S13
  • [45] SEIZURE RECURRENCE AFTER A 1ST UNPROVOKED SEIZURE IN CHILDHOOD - A STUDY OF RISK-FACTORS
    MANREZA, MLG
    GHERPELLI, JLD
    GUILHOTO, LMFF
    SOUZA, AMMH
    NAGAE, LM
    FERREIRA, VB
    COSTAS, CC
    HEISE, CO
    DIAMENT, A
    EPILEPSIA, 1995, 36 : S91 - S92
  • [46] A pilot study of post-consolidation chemoimmunotherapy for high-risk neuroblastoma (ANBL19P1): A report from the Children's Oncology Group
    Desai, Ami V.
    Naranjo, Arlene
    LaBarre, Brian
    Goldsmith, Kelly C.
    Granger, Meaghan P.
    States, Lisa
    Green, Sean
    Trunzo, Mariel
    Fitzgerald, Wendy
    DuBois, Steven G.
    Bagatell, Rochelle
    Park, Julie R.
    Marachelian, Araz
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Prognostic value of texture analysis of the primary tumour in high-risk neuroblastoma: An 18F-DOPA PET study
    Fiz, Francesco
    Bottoni, Gianluca
    Bini, Fabiano
    Cerroni, Francesca
    Marinozzi, Franco
    Conte, Massimo
    Treglia, Giorgio
    Morana, Giovanni
    Sorrentino, Stefania
    Garaventa, Alberto
    Siri, Giacomo
    Piccardo, Arnoldo
    PEDIATRIC BLOOD & CANCER, 2022, 69 (11)
  • [48] REVIEW OF SURGICAL TREATMENT IN PATIENTS ENROLLED IN THE PHASE II STUDY NB-HR07 FOR ADVANCED NEUROBLASTOMA- A REPORT FROM JAPAN NEUROBLASTOMA STUDY GROUP (JNBSG)
    Hishiki, T.
    Kuroda, T.
    Tajiri, T.
    Yoneda, A.
    Tokiwa, K.
    Muraji, T.
    Sugito, K.
    Ise, K.
    Kinoshita, Y.
    Uehara, S.
    Matsumoto, K.
    Kumagai, M.
    Soejima, T.
    Takimoto, T.
    Takahashi, H.
    Kamijo, T.
    Makimoto, A.
    Hara, J.
    Ikeda, H.
    Nakagawara, A.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 31 - 31
  • [49] Improved survival of children with advanced neuroblastoma treated by intensified therapy including myeloablative chemotherapy with stem cell transplantation: A retrospective analysis from the Tohoku Neuroblastoma Study Group
    Imaizumi, M
    Watanabe, A
    Kikuta, A
    Takano, T
    Ito, E
    Shimizu, T
    Tsuchiya, S
    Iinuma, K
    Konno, T
    Ohi, R
    Hayashi, Y
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 195 (02): : 73 - 83
  • [50] A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11
    Yoneda, Akihiro
    Shichino, Hiroyuki
    Hishiki, Tomoro
    Matsumoto, Kimikazu
    Ohira, Miki
    Kamijo, Takehiko
    Kuroda, Tatsuo
    Soejima, Toshinori
    Nakazawa, Atsuko
    Takimoto, Tetsuya
    Yokota, Isao
    Teramukai, Satoshi
    Takahashi, Hideto
    Fukushima, Takashi
    Hara, Junichi
    Kaneko, Michio
    Ikeda, Hitoshi
    Tajiri, Tatsuro
    Mugishima, Hideo
    Nakagawara, Akira
    PEDIATRIC BLOOD & CANCER, 2024, 71 (06)
12345